MedPath

A randomized controlled clinical trial study protocol of Bujing Yishi tablet in the treatment of Children and Adolescents with Low-grade Myopia

Not Applicable
Conditions
Myopia
Registration Number
ITMCTR2100004611
Lead Sponsor
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for myopia;
2. Aged 6 to 12 years;
3. The naked eye vision is below 1.0, and the myopia degree is -0.50D~3.00D;
4. Participants and their guardians with the ability to understand, and write research-related materials, and voluntarily comply with all test requirements;
5. Agree to sign an informed consent form and voluntarily participate in the research.

Exclusion Criteria

1. Participants with myopia and amblyopia / strabismus;
2. Spherical equivalent (SE)<-0.5D, or combined with pathologic myopia-related fundus changes and/or obvious visual dysfunction;
3. Subjects suffering from serious systemic diseases, such as cerebrovascular, liver, kidney, hematopoietic system, and psychiatric diseases;
4. use other related drugs or treatments within 2 weeks;
5. Participate in other clinical trial research;
6. Allergies to test drugs;
7. Incomplete understanding of the research, refusal to participate or lack of signed informed consent;

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diopter;
Secondary Outcome Measures
NameTimeMethod
visual sensitivity;best-corrected visual acuity;changes in TCM syndrome integral;convergence near point;axial length;naked acuity;
© Copyright 2025. All Rights Reserved by MedPath